PSTV
Plus Therapeutics Inc
NASDAQ: PSTV · HEALTHCARE · BIOTECHNOLOGY
$5.60
-5.88% today
Updated 2026-04-29
Market cap
$40.83M
P/E ratio
—
P/S ratio
7.83x
EPS (TTM)
$-7.25
Dividend yield
—
52W range
$3 – $24
Volume
3.6M
Plus Therapeutics Inc (PSTV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.93M | $6.05M | $6.85M | $14.73M | $10.63M | $10.00M | $14.50M | $12.20M | $7.60M | $11.66M | $11.38M | $6.41M | $2.98M | $7.00M | $303000.00 | $0.00 | $224000.00 | $4.91M | $5.82M | $5.21M |
| Revenue growth (YoY) | — | -23.7% | +13.3% | +114.9% | -27.9% | -5.9% | +45.1% | -15.9% | -37.7% | +53.4% | -2.4% | -43.7% | -53.5% | +134.6% | -95.7% | -100.0% | — | +2093.3% | +18.5% | -10.5% |
| Cost of revenue | $1.63M | $422000.00 | $1.85M | $3.39M | $3.91M | $3.84M | $4.00M | $3.42M | $2.94M | $3.19M | $2.71M | $1.32M | $1.15M | $5.37M | $2.70M | $66000.00 | $712000.00 | $9.69M | $852000.00 | $445000.00 |
| Gross profit | $6.29M | $5.63M | $5.00M | $11.34M | $6.72M | $6.16M | $10.50M | $8.78M | $4.66M | $8.47M | $8.66M | $5.09M | $1.83M | $7.00M | $-2.40M | $-66000.00 | $-488000.00 | $-4.78M | $4.97M | $4.77M |
| Gross margin | 79.4% | 93.0% | 72.9% | 77.0% | 63.2% | 61.6% | 72.4% | 71.9% | 61.3% | 72.7% | 76.1% | 79.4% | 61.5% | 100.0% | -791.1% | — | -217.9% | -97.2% | 85.4% | 91.5% |
| R&D | $21.98M | $14.76M | $17.37M | $12.23M | $9.69M | $10.90M | $13.63M | $17.07M | $15.11M | $19.00M | $16.20M | $13.36M | $5.52M | $5.37M | $3.48M | $5.32M | $9.70M | $9.69M | $10.58M | $8.38M |
| SG&A | $14.60M | $16.86M | $11.73M | $10.41M | $12.57M | $14.73M | $15.67M | $16.03M | $15.95M | $9.77M | $8.56M | $7.59M | $5.58M | $5.29M | $6.41M | $6.85M | $10.24M | $8.54M | $9.94M | $12.13M |
| Operating income | $-25.86M | $-31.35M | $-29.76M | $-21.55M | $-26.58M | $-33.03M | $-28.29M | $-30.68M | $-32.44M | $-15.29M | $-19.71M | $-20.68M | $-8.76M | $-3.66M | $-9.58M | $-12.49M | $-19.71M | $-13.32M | $-14.70M | $-15.30M |
| Operating margin | -326.2% | -518.3% | -434.3% | -146.3% | -250.1% | -330.5% | -195.1% | -251.5% | -426.9% | -131.1% | -173.2% | -322.6% | -293.7% | -52.3% | -3163.0% | — | -8800.0% | -271.1% | -252.3% | -293.5% |
| EBITDA | $-23.13M | $-26.90M | $-28.08M | $-20.11M | $-24.51M | $-28.81M | $-27.96M | $-20.55M | $-32.22M | $-21.68M | $-18.27M | $-18.49M | $-6.58M | $-532000.00 | $-8.44M | $-12.05M | $-18.85M | $-12.69M | $-8.40M | $-14.85M |
| EBITDA margin | -291.8% | -444.7% | -409.8% | -136.5% | -230.6% | -288.2% | -192.8% | -168.5% | -424.0% | -186.0% | -160.6% | -288.3% | -220.5% | -7.6% | -2784.5% | — | -8416.1% | -258.4% | -144.3% | -284.9% |
| EBIT | $-25.25M | $-28.52M | $-29.62M | $-21.79M | $-25.44M | $-29.67M | $-28.89M | $-22.18M | $-33.00M | $-22.78M | $-19.45M | $-20.64M | $-8.58M | $-1.43M | $-8.80M | $-12.47M | $-19.56M | $-13.32M | $-9.25M | $-15.30M |
| Interest expense | $199000.00 | $155000.00 | $420000.00 | $1.43M | $2.05M | $2.78M | $3.39M | $3.40M | $4.37M | $3.38M | $2.59M | $2.05M | $1.92M | $1.85M | $1.11M | $932000.00 | $711000.00 | $395000.00 | $3.72M | $3.61M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-25.45M | $-28.67M | $-30.04M | $-23.22M | $-27.49M | $-32.45M | $-32.28M | $-26.18M | $-37.37M | $-18.74M | $-22.05M | $-22.69M | $-12.63M | $-10.89M | $-8.24M | $-13.40M | $-20.27M | $-13.32M | $-12.98M | $-22.39M |
| Net income growth (YoY) | — | -12.7% | -4.8% | +22.7% | -18.4% | -18.0% | +0.5% | +18.9% | -42.8% | +49.8% | -17.6% | -2.9% | +44.3% | +13.8% | +24.3% | -62.6% | -51.3% | +34.3% | +2.5% | -72.5% |
| Profit margin | -321.0% | -474.0% | -438.3% | -157.6% | -258.7% | -324.6% | -222.6% | -214.6% | -491.8% | -160.8% | -193.7% | -353.9% | -423.5% | -155.6% | -2719.8% | — | -9051.3% | -271.0% | -222.8% | -429.4% |